Abstract
Selenium-containing compounds are in phase 2 and 3 clinical trials for prostate cancer prevention, although it is unclear how they work. A study suggests that selenium can facilitate DNA repair by activating the p53 tumor suppressor in an unusual way.
| Original language | English |
|---|---|
| Pages (from-to) | 1196-1198 |
| Number of pages | 3 |
| Journal | Nature Medicine |
| Volume | 8 |
| Issue number | 11 |
| DOIs | |
| State | Published - Nov 1 2002 |
Fingerprint
Dive into the research topics of 'Converting p53 from a killer into a healer'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver